Abstract
Biomarkers in cognitively vulnerable populations like those with coronary artery disease (CAD) may inform earlier intervention in vascular neurodegeneration. Circulating ceramide C18:0 (CerC18:0) is associated with changes in verbal memory in early neurodegeneration and CAD progression. We hypothesized that plasma CerC18:0 and its accumulation in biosynthesis pathways (catabolism of sphingomyelin (SM), salvage from monohexosylceramides (MHx), formation from sphingosine-1-phosphate (S1P)) would be associated with declining verbal memory performance in CAD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
